China’s phase 2 trial finds COVID-19 vaccine safe
updatetime:2020-07-21 15:47:55
Views：0
Source：Xinhua
File photo shows a staff member displays samples of the COVID-19 inactivated vaccine at Sinovac Biotech Ltd., in Beijing. (Xinhua File/Zhang Yuwei)
A phase 2 trial of a COVID-19 vaccine candidate in China has found that the vaccine is safe and induces an immune response, according to a new study published Monday in medical journal The Lancet.
Web Editor：MXJ
Recommend
- Global COVID-19 cases surpass 600 mln： WHO
- Regulator expands use of HPV vaccine
- China’s first domestic HPV vaccine shows 100 pct efficacy in clinical trial
- China’s vaccine regulatory system passes latest WHO assessment
- U.S. first lady tests positive for COVID-19
- China’s home-produced Omicron-specific mRNA vaccine to start trials
Popular Videos
Hot comments
- First apes at U.S. zoo receive COVID-19 vaccine made for animals， zoo official says
- China Life： Chinese women shine with She Power
- Foreign firms approved to offer VPN services in capital
- Homemade curling videos trending in China
- 86-year-old grandma in Hebei spends most her life on traditional cheongsam
- Winners of 2022 Inaugural WLA Prize announced
- Lantern Festival： A romantic celebration in China
- Two Chinese COVID-19 vaccine firms to supply vaccines to COVAX
- Media center for 20th CPC national congress to open on Oct. 12
- Six suspects arrested in HK for role in SE Asia job scam
Top Reviews
- Young artists recreate beauty of traditional Hanfu costume
- China releases photos of tallest tree
- English version of ‘Understanding Xi Jinping’s Educational Philosophy’ published
- China crowned in men’s team for 10th straight time at table tennis worlds
- China publishes Atlas of Wildlife in SW China
- Guangxi’s 10 Years： A Visit to China’s Qinzhou Port
- Congress delegate helped lift village out of poverty
- Expo highlights joint efforts in NEV development
- Racism stain of shame on ‘world democratic paradise’
- U.S. may face new COVID wave this upcoming winter： report